A Phase II Study of Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Therapy
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Benign tumours
- Focus Therapeutic Use
- Acronyms SAGE
- 08 Sep 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2019.
- 08 Sep 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2019.
- 20 Oct 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.